Pasithea Therapeutics Corp. (KTTA) - P/E multiplikatori
Pasithea Therapeutics (KTTA) depressiya va surunkali og'riqlarni davolash uchun ketamin infuziyasidan foydalanadigan markazlar tarmog'ini boshqaradi. Kompaniyaga tegishli operatsiyalar kamyob reagentlar yetkazib berish zanjiridagi uzilishlar va global dasturiy ta'minotni sinovdan o'tkazishdagi kechikishlar bilan bog'liq xavflarga duch kelmoqda. GURU.Markets dagi tarixiy narxlar dinamikasi -0.70 qiymatini ko'rsatmoqda, shu bilan birga, yetakchi neyrobiologlardan iborat xodimlar tarkibi barqaror qolmoqda va ilmiy maqsadlarga sodiqdir.
pasitheaclinics.com (KTTA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- kompaniyaning balans qiymati tafsilotlari:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Jamlagan qarzning kapitalga nisbati Pasithea Therapeutics|KTTA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Pasithea Therapeutics|KTTA - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Pasithea Therapeutics Corp|KTTA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Pasithea Therapeutics|Oraliq qoplash koeffitsiyenti pasitheaclinics.com
- foyda va bozor multiplikatorlari tafsilotlari:
KTTA - Sof daromad|Kelajakdagi sof foyda Pasithea Therapeutics|KTTA - P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori Pasithea Therapeutics|KTTA - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Pasithea|KTTA - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Pasithea Therapeutics|KTTA - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi pasitheaclinics.com|KTTA - Joriy yilda bir aksiya uchun foyda o'sishi|Kelgusi yil uchun bir aksiya uchun sof foydaning o'zgarishi prognozi Pasithea Therapeutics
- kompaniyaning sotuvlari va tushumi statistikasi:
Kompaniyaning jamlanma tahlili:KTTA (Pasithea Therapeutics Corp.)
Pasithea Therapeutics (KTTA) psixiatrik buzilishlar davolash vositalarini ishlab chiqish uchun biokomponentlar ta'minot zanjirlarini optimallashtirmoqda. Kompaniyaning P/E koeffitsiyenti dinamikasida aks etgan bozor kapitalizatsiyasining sof foydaga nisbati klinik sinovlarning kelgusidagi muvaffaqiyati uchun to'lanadigan premiumni o'lchaydi. Ushbu koeffitsiyent investorlarning joriy daromadning har bir birligi uchun premium to'lashga tayyorligini ko'rsatadi. Ushbu grafik buxgalteriya ko'rsatkichlarini aktivning real qiymatidan ajratish imkonini beradi, bu esa yuqori xavf sharoitida kapitalning adolatli tannarxini belgilaydi.
Muhim raqobatchilar
Narxning foydaga nisbati BIIB|P/E multiplikatori NBIX|Regencell (RGC) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati axsome.com AXSM|P/E multiplikatori ACADIA Pharmaceuticals ACAD|XENE - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Viking Therapeutics Inc VKTX|Supernus Pharma (SUPN) - Narxning foydaga nisbati|CPRX (Catalyst Pharmaceuticals) - Narxning foydaga nisbati|DNLI (denalitherapeutics.com) - P/E multiplikatori|Narx-foyda multiplikatori HRMY (Harmony Biosciences Holdings, Inc.)|P/E multiplikatori BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori TRVI (Trevi Pharma)|PRAX (Praxis Corp) - Kapitalizatsiyaning sof foydaga nisbati|anavex.com - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CBLL (CeriBell, Inc.)|PRTA: P/E multiplikatori|Narx-foyda multiplikatori ALEC|ANNX (Annexon Biosciences Inc.) - P/E multiplikatori|omeros.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati Neurogene (NGNE)|Biznesning o‘zini qoplash muddati AC Immune SA|P/E multiplikatori VYGR (voyagertherapeutics.com)|P/E multiplikatori Neumora NMRA|Scilex Holding - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Tevogen Bio Inc.|Alpha Cognition (ACOG) - Narxning foydaga nisbati|cogrx.com (CGTX) - P/E multiplikatori|Narxning foydaga nisbati Inhibikase Therapeutics|Cassava (SAVA) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Assertio Therapeutics (ASRT)|Biznesning o‘zini qoplash muddati Coya|Vistagen - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati OVID|Acumen Pharmaceuticals Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati CervoMed Inc|ATHE: P/E multiplikatori|Narx-foyda koeffitsiyenti Clene Nanomedicine|Narxning foydaga nisbati PepGen Corp|Jupiter Neurosciences (JUNS) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Relmada Therapeutics, Inc. (RLMD)|ANVS - Kapitalizatsiyaning foydaga nisbati|gracetx.com - Narx-foyda koeffitsiyenti|AIFF: Narx-foyda multiplikatori|Klotho Neurosciences - P/E multiplikatori|NRSN (NeuroSense Therapeutics Ltd.) - Narx-foyda multiplikatori|Reviva Pharmaceuticals (RVPH) - Narxning foydaga nisbati|MTVA (MetaVia Inc.) - Narxning foydaga nisbati|Narxning foydaga nisbati NeurAxis, Inc|Narxning foydaga nisbati HSDT|P/E multiplikatori PASG|Biznesning o‘zini qoplash muddati Neuphoria Therapeutics, Inc.|minervaneurosciences.com - Narx-foyda koeffitsiyenti|P/E multiplikatori Athira ATHA|Addex Therapeutics - P/E multiplikatori|ALZN - P/E multiplikatori|Cyclerion (CYCN) - Narxning foydaga nisbati|Protagenic (PTIX) - P/E multiplikatori|Narxning foydaga nisbati Cortigent|Kapitalizatsiyaning foydaga nisbati Avenue Therapeutics Inc. ATXI|Narxning foydaga nisbati brainstorm-cell.com (BCLI)|Narx-foyda koeffitsiyenti Cara Therapeutics, Inc CARA|P/E multiplikatori CHRO (chromocell.com)|Kompaniya qiymatining sof foydaga nisbati ELYM|Intra-Cellular Therapies Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Longboard Pharmaceuticals Inc|Marinus (MRNS) - Narxning foydaga nisbati|NKGN - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati NeuroBo Pharmaceuticals|SAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori SNPX|Trevena Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical, Inc. - Narxning foydaga nisbati|Cerevel Therapeutics - P/E multiplikatori
